In patients who have not been on a PPI within 1-2 wk or an antibiotic or bismuth within 4 wk of endoscopy, the rapid urease test (RUT) provides an accurate, inexpensive means of identifying H. pylori.
For patients who have been taking a PPI, antibiotics, or bismuth, endoscopic testing for H. pylori should include biopsies from the gastric body and antrum for histology with or without rapid urease testing.
Though culture or polymerase chain reaction (PCR) are the primary means by which antibiotic sensitivities can be determined, neither is widely available for clinical use in the United States and therefore, cannot be routinely recommended.
Endoscopic diagnostic tests are biopsy-based diagnostic methods for H. pylori infection. This include:
Advantage of histology over other diagnostic studies is its ability to detect the pathological changes associated with H. pylori infection such as inflammation, atrophy, intestinal metaplasia, and malignancy.[2]
Multiple biopsies are required for accurate diagnosis as the prevalence and density of H. pylori varies throughout the stomach. Therefore a minimum of three biopsies is taken from different sites. They are:[1][3]
Angularis
Greater curvature of the corpus
Greater curvature of the antrum
The sensitivity of histology is greatly affected by the use of medications such as bismuth, antibiotics, and PPI.[4]
A change in color of the pH sensitive indicator signifies the presence of the active infection.
The sensitivity of the RUT decreases due to medications such as bismuth-containing compounds, antibiotics, or PPIs which reduce the density and/or urease activity of H. pylori.[6]
It is recommended that biopsies are taken from two sites due to the patchy distribution of H. pylori infection after antibiotics use. The sites include:[7][4]
The body at the gastric angularis
Greater curvature of the antrum
PPIs are withheld for 1-2 wk before the performance of RUT as they reduce the sensitivity of the test.[8]